MDR E. COLI-SPEZIFISCHES ANTIGEN

European patent · EP3167903 · Deleted

Register entry

Publication number
EP3167903
Application number
EP16201732
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 17, 2014
Published
May 17, 2017
Granted
Dec 26, 2018
Deleted
Aug 25, 2026
Reason
Annual fee unpaid
IPC classes
A61K 39/00 (2006.01)
A61K 39/395 (2006.01)
A61P 31/04 (2006.01)
C07K 16/12 (2006.01)
Priority
EP 13151627 17.01.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 25, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.08.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.08.2026

  2. Feb 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.01.2025 → 31.01.2026

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Dec 8, 2022

    Transferred

    Owner
    X4 Pharmaceuticals (Austria) GmbH, Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria → Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA
    License holder
    Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA (removed)

    Published in Swissreg on 08.12.2022

  6. May 27, 2021

    Address changed

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève → Murgitroyd & Company, 4, Rue du Commerce, 1204 Genève

    Published in Swissreg on 27.05.2021

  7. Nov 26, 2020

    Licensee entered

    License holder
    Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA

    Published in Swissreg on 26.11.2020

  8. Dec 20, 2019

    Address changed

    Owner
    ARSANIS Biosciences GmbH, Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria → X4 Pharmaceuticals (Austria) GmbH, Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria

    Published in Swissreg on 20.12.2019

2 earlier entries
  1. Apr 10, 2019

    Agent entered

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève

    Published in Swissreg on 10.04.2019

  2. Jan 7, 2019

    Granted

    Published in Swissreg on 07.01.2019

Parties

Holder

Janssen Pharmaceuticals, Inc.

1125 Trenton-Harbourton Road, Titusville, NJ 08560, US

Agent

Murgitroyd & Company

4, Rue du Commerce, 1204 Genève

Inventor

ZAUNER, Gerhild

1040 Wien, AT

NAGY, Gábor

9400 Sopron, HU

SZIJARTO, Valeria

1160 Wien, AT

BADARAU, Adriana

1030 Wien, AT

NAGY, Eszter

1070 Wien, AT

MAGYARICS, Zoltán

1110 Wien, AT

GUACHALLA, Luis

1210 Wien, AT

LUKASIEWICZ, Jolanta Katarzyna

53-201 Wroclaw, PL

MIRKINA, Irina

1020 Wien, AT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.